Progyny (PGNY) Osake Kurssi
Progyny Kurssi
Viimeisten 8 vuoden aikana Progynyn liikevaihto kasvoi 51,2 % vuodessa ja ylsi 1,29 Mrd. USD:een. Osakekohtainen tulos on kasvanut 83,4 % vuodessa viimeisten 7 vuoden aikana. Progynyn nettomarginaali 4,5 % on laskenut verrattuna 13,1 %:iin muutama vuosi sitten. Progynyn 12 kuukauden konsensustavoitehinta on 35,00 USD, noin yli kurssia 23,0 %. 18 analyytikosta 15 suosittaa ostoa — kokonaiskonsensus on Osta.
Progyny osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Progyny liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Progyny -osakkeesta
Progyny Inc. is a leading fertility benefits management company. Their business model revolves around providing comprehensive fertility benefits to individuals and employers. Progyny's services include personalized care coordination, expert medical guidance, and access to a wide network of fertility specialists. By partnering with Progyny, individuals and employers are able to navigate the complex fertility landscape with ease, gaining access to innovative treatments and technologies. With a strong focus on patient outcomes and cost containment, Progyny aims to enhance the fertility journey for all involved parties. Through their unique business model, Progyny strives to empower individuals, improve outcomes, and build a more inclusive future for fertility care.
Progyny Inc is primarily active in the healthcare industry.
Progyny Inc faces competition from other companies in the fertility benefits industry such as Carrot, WINFertility, and Future Family. These companies provide similar services and solutions for infertility treatments and family-building support. However, Progyny Inc distinguishes itself by offering a comprehensive and personalized approach to fertility benefits, leveraging data analytics and providing access to a nationwide network of fertility specialists. With its innovative solutions and strategic partnerships, Progyny Inc stands out as a leading player in the market, committed to empowering individuals and couples on their journey to parenthood.
Progyny Inc. is a prominent fertility benefits management company headquartered in New York. Established in 2015, Progyny offers comprehensive fertility solutions to employers and their employees, aiming to simplify and enhance the fertility journey. With a mission to make advancements in reproductive medicine accessible to a wider population, Progyny combines innovative technology, personalized care, and financial options to cater to diverse fertility needs. This company has successfully partnered with a vast network of world-class fertility specialists and providers to deliver exceptional outcomes. Progyny Inc. continues to play a crucial role in revolutionizing fertility benefits and ensuring that individuals can pursue their dreams of starting a family smoothly.
Progyny Inc has achieved several significant milestones since its inception. The company has successfully established itself as a leader in fertility benefits management, offering comprehensive solutions to employers and individuals. Progyny Inc has rapidly expanded its network of fertility clinics and providers, ensuring a wide range of options for patients. With a focus on personalized care and cutting-edge technology, Progyny Inc has helped thousands of individuals and couples navigate their fertility journeys. The company's commitment to research and innovations in reproductive medicine has further solidified its position in the industry. Progyny Inc continues to make strides towards revolutionizing fertility care and supporting individuals in building their families.
Progyny Inc is primarily present in the United States.
Progyny Inc represents a strong commitment to reproductive health and family building. The company's corporate philosophy revolves around providing comprehensive fertility benefits and exceptional patient care. Progyny Inc strongly believes in empowering individuals and couples to make informed decisions about their fertility journeys. Their values include compassion, integrity, innovation, and a dedication to improving the lives of individuals struggling with infertility. Progyny Inc's mission is to ensure cost-effective, high-quality fertility solutions and support, helping individuals and families achieve their dream of having a baby.
Analyytikot asettavat tällä hetkellä Progyny-osakkeelle keskimääräisen tavoitehinnan 34,86 USD (mediaani: 35,00 USD), mikä merkitsee +25,1 % viimeisimpään hintaan verrattuna. Konsensus perustuu 18 analyytikkoarvioon.
18 analyytikkoa arvioi tällä hetkellä Progyny-osaketta: 15 suosittaa ostoa, 3 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Progyny-yhtiöltä 1,37 Mrd. USD liikevaihtoa ja 1,24 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Progyny-osake noteerataan hintaan 25,53 EUR (28,46 USD).
Progyny-osake (PGNY) on listattuna 1 pörssissä, muun muassa: NASDAQ (PGNY).
Progyny Inc is a leading healthcare company specializing in fertility treatments and services. The company was founded in 2008 and is headquartered in New York City. Progyny offers a comprehensive range of services to its customers, ranging from diagnosis to family support. Progyny provides its customers with personalized fertility programs that consider both medical and psychological aspects. The program begins with a comprehensive diagnosis and counseling to determine where the customer is on the fertility spectrum and what treatment options are available to them. Then, a treatment plan tailored to the specific needs of the customer is created. Progyny works with a range of doctors and clinics to ensure that its customers receive the best available treatment. An important part of Progyny's business model is its fertility network. The company has partnership agreements with over 500 fertility clinics and centers nationwide, producing over 2,000 success stories per year. Thanks to its network, Progyny has the ability to offer its customers comprehensive access to diagnostic and therapeutic services to achieve a successful pregnancy. Progyny also offers an online platform that facilitates customer access to its services. The website and mobile app provide a user-friendly interface for customers to view their lab results and medical records, as well as manage their treatment plans. Additionally, the platform provides a comprehensive collection of resources and information on fertility. Another key component of Progyny's offering is its financing options. Fertility treatments can be expensive, and many insurance plans do not cover them. However, Progyny has developed its own financing tools to help customers bear the costs of treatment. The company offers flexible financing options, discounts for self-pay patients, and a special membership, among other options. Progyny aims to provide a comprehensive suite of services that meet the needs and desires of its customers. The company focuses on delivering cutting-edge technologies to improve the success rate of fertility treatments, as well as an unmatched customer experience. Progyny strives to be a reliable partner for its customers, supporting them at every step of their fertility journey.
odotettu liikevaihto Progyny on 1,37 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Progyny on 110,78 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Progyny:n hinta-voitto-suhde (P/E) on tällä hetkellä 22,98. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Progyny-osakkeen arvostusta.
Progyny:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,85. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Progyny-osakkeen arvostuskennuslukuna.
Progyny:n Eulpool-laatuscore on 5/10.
Progyny:n ISIN on US74340E1038. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Progyny:n WKN on A2PT5Q. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Progyny:n ticker on PGNY. Tämä pörssinoteeraus käytetään Progyny-osakkeiden kauppaan pörssissä.
Progyny osake
Progyny vertaisryhmä
Progyny Ticker
Progyny FIGI
Kaikki tunnusluvut ja syvällinen analyysi Progyny:sta
Meidän osakeanalyysimme Progyny-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Progyny:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: